Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15572476 | Publishing Date : 17-Apr-2020 | No. of pages : 97
Detailed TOC of Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, Status and Forecast 2020-2026
1 Report Overview1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue
1.4 Market Analysis by Therapy
1.4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Therapy: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Others
1.5 Market by End Users
1.5.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by End Users: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Industry
1.6.1.1 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Perspective (2015-2026)
2.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Growth Trends by Regions
2.2.1 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Market Size
3.1.1 Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Revenue (2015-2020)
3.1.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio
3.2.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2019
3.3 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Key Players Head office and Area Served
3.4 Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Solution and Service
3.5 Date of Enter into B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Therapy (2015-2026)
4.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Historic Market Size by Therapy (2015-2020)
4.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Therapy (2021-2026)
5 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Breakdown Data by End Users (2015-2026)
5.1 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020)
5.2 Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by End Users (2021-2026)
6 North America
6.1 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2015-2020)
6.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Key Players in North America (2019-2020)
6.3 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Therapy (2015-2020)
6.4 North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020)
7 Europe
7.1 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2015-2020)
7.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Key Players in Europe (2019-2020)
7.3 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Therapy (2015-2020)
7.4 Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020)
8 China
8.1 China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2015-2020)
8.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Key Players in China (2019-2020)
8.3 China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Therapy (2015-2020)
8.4 China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020)
9 Japan
9.1 Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size (2015-2020)
9.2 B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Key Players in Japan (2019-2020)
9.3 Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Therapy (2015-2020)
9.4 Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020)
10Key Players Profiles
10.1 Amgen
10.1.1 Amgen Company Details
10.1.2 Amgen Business Overview and Its Total Revenue
10.1.3 Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
10.1.4 Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020))
10.1.5 Amgen Recent Development
10.2 Bayer
10.2.1 Bayer Company Details
10.2.2 Bayer Business Overview and Its Total Revenue
10.2.3 Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
10.2.4 Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
10.2.5 Bayer Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Details
10.3.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
10.3.3 Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
10.3.4 Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
10.3.5 Bristol-Myers Squibb Recent Development
10.4 Merck Serono
10.4.1 Merck Serono Company Details
10.4.2 Merck Serono Business Overview and Its Total Revenue
10.4.3 Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
10.4.4 Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
10.4.5 Merck Serono Recent Development
10.5 Roche
10.5.1 Roche Company Details
10.5.2 Roche Business Overview and Its Total Revenue
10.5.3 Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
10.5.4 Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
10.5.5 Roche Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Details
10.6.2 AstraZeneca Business Overview and Its Total Revenue
10.6.3 AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
10.6.4 AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
10.6.5 AstraZeneca Recent Development
10.7 AbbVie
10.7.1 AbbVie Company Details
10.7.2 AbbVie Business Overview and Its Total Revenue
10.7.3 AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
10.7.4 AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
10.7.5 AbbVie Recent Development
10.8 Novartis
10.8.1 Novartis Company Details
10.8.2 Novartis Business Overview and Its Total Revenue
10.8.3 Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Introduction
10.8.4 Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
10.8.5 Novartis Recent Development
11Analyst's Viewpoints/Conclusions
12Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of Figures, Tables and Charts Available in Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, Status and Forecast 2020-2026
List of TablesTable 1. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue
Table 3. Ranking of Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth Rate by Therapy (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiation Therapy
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players to Combat Covid-19 Impact
Table 13. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Growth by End Users (US$ Million): 2020 VS 2026
Table 14. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Regions (2015-2020)
Table 17. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players
Table 24. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Players (2015-2020)
Table 26. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2019)
Table 27. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product Solution and Service
Table 30. Date of Enter into B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Therapy (2015-2020) (Million US$)
Table 33. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by Therapy (2015-2020)
Table 34. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Therapy (2021-2026)
Table 35. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by End Users (2015-2020)
Table 36. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020) (Million US$)
Table 37. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size Share by End Users (2021-2026)
Table 38. North America Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share (2019-2020)
Table 40. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Therapy (2015-2020) (Million US$)
Table 41. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Therapy (2015-2020)
Table 42. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020) (Million US$)
Table 43. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by End Users (2015-2020)
Table 44. Europe Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share (2019-2020)
Table 46. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Therapy (2015-2020) (Million US$)
Table 47. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Therapy (2015-2020)
Table 48. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020) (Million US$)
Table 49. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by End Users (2015-2020)
Table 50. China Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share (2019-2020)
Table 52. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Therapy (2015-2020) (Million US$)
Table 53. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Therapy (2015-2020)
Table 54. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020) (Million US$)
Table 55. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by End Users (2015-2020)
Table 56. Japan Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share (2019-2020)
Table 58. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by Therapy (2015-2020) (Million US$)
Table 59. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Therapy (2015-2020)
Table 60. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size by End Users (2015-2020) (Million US$)
Table 61. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by End Users (2015-2020)
Table 62. Amgen Company Details
Table 63. Amgen Business Overview
Table 64. Amgen Product
Table 65. Amgen Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020) (Million US$)
Table 66. Amgen Recent Development
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Product
Table 70. Bayer Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020) (Million US$)
Table 71. Bayer Recent Development
Table 72. Bristol-Myers Squibb Company Details
Table 73. Bristol-Myers Squibb Business Overview
Table 74. Bristol-Myers Squibb Product
Table 75. Bristol-Myers Squibb Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020) (Million US$)
Table 76. Bristol-Myers Squibb Recent Development
Table 77. Merck Serono Company Details
Table 78. Merck Serono Business Overview
Table 79. Merck Serono Product
Table 80. Merck Serono Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020) (Million US$)
Table 81. Merck Serono Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Product
Table 85. Roche Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020) (Million US$)
Table 86. Roche Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Product
Table 90. AstraZeneca Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020) (Million US$)
Table 91. AstraZeneca Recent Development
Table 92. AbbVie Company Details
Table 93. AbbVie Business Overview
Table 94. AbbVie Product
Table 95. AbbVie Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020) (Million US$)
Table 96. AbbVie Recent Development
Table 97. Novartis Business Overview
Table 98. Novartis Product
Table 99. Novartis Company Details
Table 100. Novartis Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Therapy: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Others Features
Figure 5. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by End Users: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Report Years Considered
Figure 11. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share by Players in 2019
Figure 16. Global Top B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue in 2019
Figure 18. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Amgen Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
Figure 24. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Bayer Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
Figure 26. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bristol-Myers Squibb Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
Figure 28. Merck Serono Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Merck Serono Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
Figure 32. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AstraZeneca Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
Figure 34. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. AbbVie Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
Figure 36. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novartis Revenue Growth Rate in B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
Keyplayers in Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, Status and Forecast 2020-2026
AmgenBayer
Bristol-Myers Squibb
Merck Serono
Roche
AstraZeneca
AbbVie
Novartis